Search Results - "TEMIRBULATOV, I. I."

Pharmacogenetic Markers of Favipiravir Safety in COVID-19 Treatment by Temirbulatov, I. I., Kryukov, A. V., Mirzaev, K. B., Denisenko, N. P., Abdullaev, S. P., Petrova, A. V., Tkach, E. P., Shipacheva, A. V., Sychev, D. A.

“…The aim of the study was to evaluate the associations of different variants of AOX1 and CYP1A2 genes with safety parameters of favipiravir therapy in patients…”
Get full text

The rs11385942 and rs657152 variants are not associated with COVID-19 severity and outcomes in patients treated with favipiravir and remdesivir by Abdullaev, Sh. P., Denisenko, N. P., Temirbulatov, I. I., Kachanova, A. A., Tuchkova, S. N., Mikhaylenko, E. V., Kryukov, A. V., Valiev, T. T., Mirzaev, K. B., Sychev, D. A.

“…Background . There is a mounting evidence in the scientific literature that susceptibility to SARS-CoV-2 infection could vary. The severity of COVID-19…”
Get full text

The Effect of Carriage of CYP3A53 and CYP3A422 Polymorphic Variants on the Safety of Remdesivir Therapy in Patients with COVID-19 by TEMIRBULATOV, I. I., KRYUKOV, A. V., MIRZAEV, K. B., DENISENKO, N. P., ABDULLAEV, S. P., ZHIRYAKOVA, A. S., SHEVCHUK, Y. V., VECHORKO, V. I., AVERKOV, O. V., SYCHEV, D. A.

“…The aim of the study was to assess the association of polymorphic variants CYP3A5*3 6986 A>G rs776746 and CYP3A4*22 rs35599367 C>T with the safety parameters…”
Get full text

Model for predicting risk of developing drug-induced liver injury during remdesivir therapy: observational prospective open case-control study by Shevchuk, Yu. V., Kryukov, A. V., Temirbulatov, I. I., Sychev, I. V., Mirzaev, K. B., Denisenko, N. P., Abdullaev, Sh. P., Tuchkova, S. N., Vechorko, V. I., Averkov, O. V., Sychev, D. A.

“…Remdesivir is a drug widely used for the etiotropic treatment of COVID-19. According to a number of studies, the incidence of adverse reactions during…”
Get full text

Safety of Pharmacotherapy in COVID-19 Patients: A Literature Review by Kryukov, A. V., Zhiryakova, A. S., Shevchuk, Yu. V., Matveev, A. V., Vechorko, V. I., Averkov, O. V., Glagolev, S. V., Temirbulatov, I. I., Mirzaev, K. B., Denisenko, N. P., Abdullaev, Sh. P., Sychev, D. A.

“…The safety of COVID-19 pharmacotherapy is a relevant issue, first of all, because of the current lack of experience with using particular medicinal products…”
Get full text

Effect of polymorphisms in CYP3A422 (rs35599367) C>T, CYP3A53 (rs776746) A>G, ABCB1 (rs4148738) C>T and ABCB1 (rs1045642) C>T genes on apixaban anticoagulation: pilot study results by Sychev, I. N., Fedina, L. V., Osipov, A. S., Temirbulatov, I. I., Tataroy, O. Yu, Sozaeva, Zh. A., Akmalova, K. A., Denisenko, N. P., Abdullaev, S. P., Kachanova, A. A., Grishina, E. A., Mirzaev, K. B., Sychev, D. A.

“…Introduction . Apixaban is a direct oral anticoagulant prescribed for treatment and prevention of venous thromboembolism (VTE) and for prevention of stroke in…”
Get full text

Pharmacogenetics of the safety of phenazepam in alcohol withdrawal syndrome: haplotype and combinatorial analyses of polymorphic variants in the pharmacokinetic factor genes by Ivashchenko, D. V., Tereshchenko, O. V., Temirbulatov, I. I., Akmalova, K. A., Grishina, E. A., Zastrozhin, M. S., Savchenko, L. M., Bryun, E. A., Sychev, D. A.

“…Phenazepam is a benzodiazepine tranquilizer that is widely used in Russia. The drug is metabolized by cytochrome P450 3A (CYP3A) isozymes. Since their…”
Get full text

Day-by Day Blood Pressure Variability: Methodological Aspects, Prognostic Value, Effects of Antihypertensive Therapy by Ostroumova, O D, Borisova, E V, Guseva, T F, Temirbulatov, I I

“…In this article we present problems of prognostic value of day-by-day blood pressure (BP) variability, its role in development and progression of damage of…”
Get more information

Distribution of Genetic Factors Associated with Severe COVID-19 in Ethnic Groups of the Eastern Caucasus by Abdullaev, S. Р., Mammaev, К. М.-В., Denisenko, N. Р., Temirbulatov, I. L., Kachanova, A. А., Mikhaylenko, E. V., Kryukov, А. V., Valiev, Т. Т., Mirzaev, К. В., Mammaev, S. N., Sychev, D. А.

“…Background . Previously, genetic markers rs11385942 G>GA and rs657152 C>A of disease severity were identified for COVID-19. The study of the prevalence of…”
Get full text

Geographic distribution of the LZTFL1 SNP markers associated with severe COVID-19 in Russia and worldwide by Balanovska, EV, Gorin, IO, Petrushenko, VS, Chernevskiy, DK, Koshel, SM, Temirbulatov, II, Pylev, VYu, Agdzhoyan, AT

“…The correlation between the risk of death from COVID-19 and the patient's ethnogeographic origin has been previously detected. LZTFL1 gene was identified as a…”
Get full text

Evaluation of the association of CES1 (rs2244613) polymorphisms with the safety of remdesivir in hospitalized patients with COVID-19 by Temirbulatov, I. I., Kryukov, A. V., Mirzaev, K. B., Denisenko, N. P., Abdullaev, Sh. P., Kachanova, A. A., Sozaeva, Zh. A., Zhiryakova, A. S., Shevchuk, Yu. V., Vechorko, V. I., Averkov, O. V., Sychev, D. A.

“…Introduction . An outbreak of novel COVID-19 infection has become a real challenge for the entire human society, and first of all for the healthcare services…”
Get full text

Pharmacogenetics of antiviral agents for the treatment of COVID-19 by Temirbulatov, I. I., Kryukov, A. V., Sychev, D. A.

“…Presented a literature review on the possible influence of pharmacogenetic markers on the efficacy and safety of COVID-19 therapy. Clinical studies of…”
Get full text

Clinical pharmacogenetics of angiotensin II receptor blockers by Sinitsina, I. I., Boyarko, A. V., Temirbulatov, I. I.

“…This scientific review presents a current data on the effect of genetic polymorphism of CYP2C9 genes and genes encoding components of the…”
Get full text

Variation of Genomic Sites Associated with Severe Covid-19 Across Populations: Global and National Patterns by Balanovsky, Oleg, Petrushenko, Valeria, Mirzaev, Karin, Abdullaev, Sherzod, Gorin, Igor, Chernevskiy, Denis, Agdzhoyan, Anastasiya, Balanovska, Elena, Kryukov, Alexander, Temirbulatov, Ilyas, Sychev, Dmitriy

“…Information about the distribution of clinically significant genetic markers in different populations may be helpful in elaborating personalized approaches to…”
Get full text

Controversial Points in the Assessment of the Quality of Generic Esomeprazole Formulations by Serebrova, S. Yu, Prokof’ev, A. B., Krasnykh, L. M., Vasilenko, G. F., Smolyarchuk, E. A., Kareva, E. N., Smirnov, V. V., Zhuravleva, M. V., Eremenko, N. N., Lazareva, N. B., Starodubtsev, A. K., Kurguzova, D. O., Barkov, A. O., Abrosimov, A. G., Koniev, T. I., Sivkov, A. S., Temirbulatov, I. I.

“…A comparative dissolution kinetics test was performed to model the actions of pathological duodenogastric reflux and therapeutic acid suppression on the…”
Get full text

A problem with oblique derivative for the wave equation by Temirbulatov, S. I.

Get full text

Pharmacogenetic testing by polymorphic markers 681G>A and 636G>A CYP2C19 gene in patients with acute coronary syndrome and gastric ulcer in the Republic of Sakha (Yakutia) by Fedorinov, Denis S, Mirzaev, Karin B, Ivashchenko, Dmitriy V, Temirbulatov, Ilyas I, Sychev, Dmitriy A, Maksimova, Nadezda R, Chertovskih, Jana V, Popova, Nyurguiana V, Tayurskaya, Ksenia S, Rudykh, Zoya A

“…The focus of the study is to determine the prevalence of CYP2C19 alleles, associated with the risk of changes in the pharmacological response to clopidogrel…”
Get more information

Effectiveness of collagen plasty in complex treatment of localized pyopneumothorax by Seleznev, Iu P, Ivanov, S V, Temirbulatov, V I, Sergeev, L V, Sergachev, D A, Iakovenko, O V

“…The work is based on an analysis of results of treatment of 25 patients with localized pleuro-pulmonary cavities by the methods of minor surgery. During…”
Get more information

The use of late temporary bronchial occlusion in the combined treatment of patients with acute suppurative lung abscesses by Seleznev, Iu P, Ivanov, S V, Temirbulatov, V I, Sergeev, L V, Sergachev, D A

“…The article presents results of late temporary occlusion of bronchi for prevention of chronicalization of the inflammatory process in 34 patients with acute…”
Get more information